Transitions of Care - Medication Reconciliation and Follow Up

Key Points

• Medication reconciliation must compare preadmission, inpatient, and intended discharge therapy.
• Document why medications were started, stopped, held, or dose-adjusted.
• Pending results need a named clinician responsible for follow-up.
• Assess function, cognition, caregiver capacity, transportation, and medication access before discharge.
• Use teach-back rather than assuming written instructions were understood.
• High-risk therapies need explicit monitoring plans.
• Follow-up timing should match clinical risk.
• Communication with the receiving clinician or facility is part of the treatment plan.

Algorithm

1. Confirm medical stability and destination.
2. Reconcile medications and identify every intentional change.
3. Review pending tests and assign responsibility.
4. Assess mobility, cognition, equipment, wound, nutrition, and caregiver needs.
5. Schedule risk-appropriate follow-up and laboratory monitoring.
6. Provide written instructions and use teach-back.
7. Transmit the discharge summary and actionable information to the next care team.
8. Arrange early post-discharge contact for high-risk patients.

Clinical Synopsis & Reasoning

The discharge process should reconcile the preadmission medication list, inpatient medications, and intended discharge regimen into one authoritative list. Identify medications that were stopped, started, changed in dose, or held temporarily and document the reason for each change. Particular attention is needed for anticoagulants, insulin, diuretics, antihypertensives, opioids, sedatives, antibiotics, steroids, and medications whose dose depends on kidney function. A common failure is allowing a prehospital drug that was intentionally stopped to reappear automatically on a pharmacy list or skilled-nursing medication administration record.

Transitions involve more than medications. Determine whether the patient can transfer, walk, toilet, eat, use inhalers or injections, manage wounds, and obtain prescribed equipment. Confirm who will perform these tasks if the patient cannot. Review cognition, hearing, language, transportation, cost, pharmacy access, and caregiver availability. Pending pathology, cultures, imaging reads, and laboratory tests need a named clinician responsible for review and action. Follow-up should be timed to clinical risk rather than scheduled generically several months later.

Use teach-back to test understanding. A technically accurate discharge packet is insufficient if the patient cannot explain the plan. Provide written instructions that separate daily medications from as-needed medicines and clearly state which previous medications should no longer be taken. Communicate the hospital course and unresolved issues to the primary care clinician, specialist, home-health team, or facility receiving the patient.

Treatment Strategy & Disposition

Before discharge, complete medication reconciliation with patient and caregiver participation when possible. Arrange the first doses or prescriptions for time-sensitive medications and verify that cost or formulary barriers will not prevent access. If warfarin, insulin, diuretics, or other monitored therapies change, specify the next laboratory test and who will act on it. For antibiotics, state indication and stop date. For temporary holds, state exactly when and under what condition the medicine should restart.

Build follow-up around risk. Recent heart failure, acute kidney injury, anticoagulation change, new oxygen, wound care, or complex diabetes therapy may require contact within days. Functional decline may require home health, physical or occupational therapy, durable medical equipment, or rehabilitation. Review warning signs using concrete actions, such as call today for increasing leg swelling or go to the emergency department for black stool with dizziness.

Post-discharge phone calls or pharmacist review can identify discrepancies early, especially in patients with polypharmacy or cognitive impairment. When discharge is to a skilled-nursing facility, send current orders, medication rationale, code status, wound instructions, follow-up needs, and pending results rather than relying on a generic summary. The safest transition makes ownership explicit: every unresolved problem should have a responsible person, next step, and time frame.

Epidemiology / Risk Factors

• Older adults experience frequent transitions among hospital, rehabilitation, long-term care, and home.
• Polypharmacy and multimorbidity increase discrepancy risk.
• Medication-related problems are a common contributor to post-discharge adverse events.
• Functional decline can make a previously safe home plan unsafe even when the acute illness has improved.

Investigations

High Risk Elements

Pharmacology

Prognosis / Complications

• Well-coordinated transitions reduce preventable medication errors and delays in follow-up.
• Unresolved discrepancies can cause readmission, bleeding, hypoglycemia, hypotension, or disease recurrence.
• Early outpatient reassessment is particularly valuable after high-risk medication changes.
• Caregiver understanding strongly influences adherence in cognitively impaired patients.

Patient Education / Counseling

• Bring the updated medication list to every appointment.
• Discard or clearly separate medications that were permanently stopped.
• Know which symptoms require a call versus emergency care.
• Confirm the date and purpose of follow-up appointments before leaving.
• Ask who will contact you about tests that are still pending.
• Use one pharmacy when possible to improve medication oversight.

Notes

A safe transition can be audited with one question: if a problem occurs tomorrow, will the patient and next clinician know what to do? Discharge summaries should prioritize actionable information over copied inpatient detail. The medication list, pending tests, follow-up tasks, functional limitations, and goals of care should be immediately visible.

A transition plan should also reconcile nonmedication treatment changes. New oxygen, mobility restrictions, wound supplies, dietary restrictions, glucose-monitoring frequency, and device care can fail for the same reason medications fail: responsibility is unclear. When a patient is going to a facility, verify that the receiving setting can actually provide the required therapy before transport. When the patient is going home, confirm that essential equipment is delivered or scheduled and that the caregiver has demonstrated any technical task such as injections or dressing changes. These operational details are part of medical safety because a theoretically correct plan that cannot be executed is not a safe discharge.

References

1. American Geriatrics Society: 2023 AGS Beers Criteria — Link
2. American Geriatrics Society: Guidelines and Recommendations — Link